查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1516944

动物用诊断药的全球市场的评估:各产品，各技术，各动物类型，各用途，各终端用户，各地区，机会，预测，2017年～2031年

Veterinary Diagnostics Market Assessment, By Product, By Technology, By Animal Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

2024-2031年预测期间，全球兽医诊断市场规模将以8.34%的复合年增长率成长，从2023年的62.4亿美元成长到2031年的118.4亿美元。该市场已经经历了显着的成长，并且随着时间的推移预计将增长得更加多样化。

非人类动物来源物质中化学物质的测量和鑑定是兽医诊断药理学的一部分。临床评估是兽医诊断的一个组成部分。临床评估为兽医提供了识别疾病或促使临床症状异常的疾病所需的资讯。兽医诊断技术的发展进步，包括分子诊断、影像模式和即时护理 (PoC) 测试，大大提高了我们诊断动物疾病的能力。随着诊断速度和准确性的提高，随着越来越多的兽医和宠物主人寻求完整医疗保健的尖端解决方案，这些进步也帮助整个行业蓬勃发展。随着包括人畜共通传染病在内的传染病在动物中变得越来越普遍，准确、快速的诊断至关重要。就像人类一样，动物随着年龄的增长也容易罹患慢性疾病。需要透过诊断来帮助早期发现和管理关节炎、糖尿病和癌症等疾病，这不仅是由于宠物的衰老，也是由于人们越来越重视预防性护理。动物中慢性病和传染病的日益普及预计将增加对兽医诊断的需求。

新兴国家可支配收入的增加、护理点诊断技术的改进、人畜共患疾病的流行、兽医数量的增加以及动物健康支出的增加推动了兽医诊断市场的发展。技术进步和政府措施也是支持市场成长的因素。

本报告提供全球动物用诊断药市场相关调查，提供市场概要，以及各产品，各技术，各动物类型，各用途，各终端用户，各地区趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 调查手法

第2章 计划的范围和定义

第3章 摘要整理

第4章 全球动物用诊断药市场预测，2017年～2031年

  • 市场规模与预测
  • 各产品
  • 各技术
  • 各动物类型
  • 各用途
  • 各终端用户
  • 各地区
  • 各企业市场占有率(%)、2023年

第5章 全球动物用诊断药市场预测，各地区，2017年～2031年

  • 北美
  • 欧洲
  • 亚太地区
  • 南美
  • 中东·非洲

第6章 市场製图，2023年

第7章 宏观环境和产业结构

  • 需求供给分析
  • 进出口分析
  • 价值链分析
  • PESTEL分析
  • 波特的五力分析

第8章 市场动态

第9章 法规结构和革新

第10章 主要加入企业的形势

第11章 价格分析

第12章 案例研究

第13章 主要加入企业预测

  • Thermo Fisher Scientific, Inc.
  • Zoetis Services LLC
  • IDEXX Laboratories, Inc.
  • Heska Corporation
  • bioMerieux SA
  • FUJIFILM Holdings America Corporation
  • Ring Biotechnology Co Ltd.
  • PepiPets, Inc.
  • Bio-Rad Laboratories, Inc.
  • Neogen Corporation

第14章 策略性建议

第15章 咨询方式和免责声明

Product Code: MX11619

Global veterinary diagnostics market is projected to witness a CAGR of 8.34% during the forecast period 2024-2031, growing from USD 6.24 billion in 2023 to USD 11.84 billion in 2031. The market has undergone substantial growth and is expected to further grow manifolds as we further advance in time.

Measuring and identifying chemicals in non-human animal source materials is part of veterinary diagnostics. A clinical evaluation is an integral part of veterinary diagnostics. It provides the veterinarian with the information needed to identify the illness or illnesses causing the irregularities in the clinical signs. The capacity to diagnose diseases in animals has greatly increased due to ongoing developments in veterinary diagnostic technologies, such as molecular diagnostics, imaging modalities, and point-of-care (PoC) testing. Along with improving diagnostic speed and accuracy, these advancements also help the industry, as a whole, to thrive as more veterinarians and pet owners look for cutting-edge solutions for complete healthcare. Accurate and prompt diagnoses are critical because infectious diseases, including zoonotic diseases, are becoming more common in animals. Animals are prone to age-related and chronic diseases, much like people. The need for diagnostics that can help in the early identification and management of illnesses, including arthritis, diabetes, and cancer, is fueled by the aging pet population as well as an increasing emphasis on preventative healthcare. It is anticipated that the need for veterinary diagnostics will increase due to the rising prevalence of both chronic and infectious animal illnesses.

The veterinary diagnostic market has grown as a result of several factors, including rising levels of disposable income in developing nations, improvements in point-of-care diagnostic technology, an increase in the prevalence of zoonotic diseases, the growing number of veterinarians, and increased spending on animal health. Technological advancements and government initiatives are also factors that support market growth. For instance, the first on-farm mastitis tests were introduced by Zoetis Services LLC in August 2023. In several European markets, Zoetis Services LLC introduced Vetscan Mastigram+, a quick on-farm mastitis test. In eight hours, a straightforward flow dipstick test can identify Gram-positive mastitis, allowing its users to know about the test results before the next milking cycle of an animal. Given that antimicrobial treatment is typically only beneficial for Gram-positive instances, this information can be used by a farmer or veterinarian to provide more individualized therapy and guarantee that antimicrobial usage is limited to cows that truly require it.

Advent of Precision Medicine in Veterinary Diagnostics Leading to Market Expansion

With customized diagnostics and therapies that can improve the health and welfare of animals, precision medicine is completely changing the veterinary care industry. Precision medicine enables veterinarians to give more precise diagnosis, tailored treatments, and improved outcomes by using genomic sequencing, personalized diagnostics, and targeted therapeutics. Rapid developments in technology like genome sequencing, gene editing, and targeted medicines will continue to propel the use of precision medicine in veterinary care. It is anticipated that the development of increasingly advanced instruments and methods for more accurate animal diagnosis and treatment will advance the understanding of animal genetics. Precision medicine in veterinary medicine allows early identification of animals at risk of any specific diseases and helps implement focused therapies. This proactive strategy makes it possible to prevent or diagnose diseases at the earliest stage when treatments are most effective. Furthermore, precision medicine can be used to establish nutritional regimens based on the genetic profile of an animal.

Veterinarians can tailor diets to an animal's specific nutritional requirements and genetic variances to sustain health, prevent illness, and enhance performance. Precision medicine has made selective breeding methods possible by discovering the genes linked to both illness risks and attractive features. By using this information, breeders can enhance genetic variety within animal populations, decrease the incidence of inherited illnesses, and make better breeding selections. Therefore, the application of precision medicine in veterinary care may fuel the market for veterinary diagnostics in future expansion. For instance, to develop a companion diagnostic test for TIBSOVO, an isocitrate dehydrogenase-1 (IDH1) inhibitor, QIAGEN N.V. and Les Laboratories Servier collaborated in March 2023. The treatment for acute myeloid leukaemia (AML), a blood malignancy, was introduced. As part of this partnership, QIAGEN N.V. would create and certify a real-time in-vitro polymerase chain reaction (PCR) test that can identify IDH1 gene alterations in whole blood and bone marrow aspirates from AML patients.

Rising Prevalence of Zoonotic Diseases Positively Impacts Market Growth

Growing rates of zoonotic diseases, infections that spread from animals to people, are a major factor propelling the global veterinary diagnostics market. There is a growing need for early and precise diagnostic techniques since these diseases lead to major health hazards to both humans and animals. Veterinary diagnostics are essential to detect, track, and manage these illnesses and for averting epidemics and guaranteeing the public's safety. Technological developments in diagnostic methods, including immunoassays, imaging, and molecular diagnostics, have improved the speed and accuracy of zoonotic pathogen detection. This development has increased the trust that pet owners and veterinary professionals have in the efficacy of diagnostic testing, which is propelling market expansion even more. Additionally, the cost of veterinary treatment, particularly diagnostics, has increased because of growing awareness of the significance of animal health and how it directly affects human health. The cattle industry significantly influences the market for veterinary diagnostics. To guarantee food safety and stop the spread of disease, routine screening and monitoring are essential since livestock animals are important reservoirs of zoonotic diseases. Funding and government programs to prevent zoonotic illnesses are also essential to the growth of the business. Global regulatory organizations are highlighting the necessity of strict animal health surveillance, which is driving the uptake of cutting-edge diagnostic technologies. In summary, one of the main factors propelling the global veterinary diagnostics market is the rising prevalence of zoonotic infections. This trend is expected to continue, propelled by technological advancements, increased awareness, and supportive government policies aimed at safeguarding both animal and human health. The growing incidence of zoonotic illnesses, which is further highlighted by the avian influenza pandemic in 2023, has resulted in significant expansion of the worldwide veterinary diagnostics industry. This outbreak made clear how urgently reliable veterinary diagnostic technologies were needed. Significant instances of avian influenza were recorded in January 2023 in several regions, including the United States and Japan. This prompted widespread slaughter of poultry and heightened surveillance measures. This incident served as a reminder of how crucial it is to identify zoonotic infections early and treat them well to stop their spread. Investments in veterinary diagnostics increased in the wake of the 2023 avian influenza outbreak as both the public and business sectors realized how important these instruments are for maintaining animal health and protecting public health.

Increasing Dominance of Molecular Diagnostics Segment Leading to Market Growth

Over the projection period, the molecular diagnostics segment is anticipated to have significant expansion because of the increased inclination of livestock and pet owners towards speedy test results that are also reasonably priced. The growing number of tests intended to detect common animal illnesses such as feline leukemia, canine parvovirus, heartworm, and infectious peritonitis is expected to propel the segmental expansion. The rise in the frequency of diseases affecting companion animals and livestock, the growing number of pet and livestock owners, their growing concern for their animals' health, and the availability of reasonably priced immunoassay tests that enable frequent testing at home are all factors driving this market's expansion. The need for molecular diagnostic tests is rising due to the rising number of avian influenza cases in farm animals, which is propelling the growth of this market.

In addition, Ring Biotechnology Co Ltd. introduced petrapidtest.com, a formal website, in January 2022 to promote the Flexy Pet Rapid Test. These kits, which might be useful for pet owners and veterinary clinics, are based on lateral flow immunoassay, enzyme-linked immunosorbent assay (ELISA), and real-time PCR to diagnose diseases in companion animals. Among these, real-time PCR is specifically made for small veterinary clinics and is capable of verifying the presence of parasites, mycoplasma, and viruses. The players' marketing campaigns contribute to the growth of the segment. Thus, with the increasing cases of avian influenza in livestock animals, increased pet adoption, and new product launches, the segment is expected to show significant growth over the forecast period.

North America to Dominate the Veterinary Diagnostics Market

North America accounts for the highest market share in the veterinary diagnostics market. This is because of the well-established veterinary healthcare infrastructure, the widespread use of cutting-edge technology, high disposable money, and the existence of significant businesses. These businesses' strategic actions keep boosting the expansion of the regional market. In April 2022, Zoetis Services LLC introduced AI blood smear testing for dogs and cats, enhancing its Vetscan Imagyst platform. Furthermore, the market under study is expanding due to the growing number of veterinary practitioners. For example, the U.S. Bureau of Labour Statistics stated in September 2022 that employment of veterinarians is expected to expand by 19% between 2021 and 2031, which is substantially greater than the average growth rate of all occupations. Additionally, according to the same source, there will be 4,800 expected openings for veterinarians annually on average during the next ten years. Hence, the growing number of veterinarians is fueling the demand for veterinary diagnostic services, which in turn is propelling the market under study's expansion. One of the main factors propelling market revenue growth in this region is the growing number of government efforts encouraging students to work in the veterinary health industry. For example, Ohio State's MPH-VPH veterinary healthcare program equips students with the public health credentials necessary to oversee zoonotic disease prevention and control initiatives across the nation.

Future Market Scenario (2024-2031F)

The main factors contributing to the anticipated growth of the veterinary diagnostics market are rising pet ownership, the increasing prevalence of zoonotic diseases, and, thus, the rising requirement to conduct diagnostic tests for pets and animals. However, the growing the need to have precision medicine to maintain healthy livestock animals and pets is also going to fuel the market growth in the future. Given that technology is advancing, cutting-edge technology in the area is expected. Players in this market are expanding at an unparalleled rate, introducing cost-effective and efficient technologies. Government policies and policies made by welfare bodies are also greatly fueling the market expansion. For instance, PepiPets, Inc. launched a new mobile diagnostic testing service in August 2022. Its users were able to conduct diagnostic testing for their pets at home after the new service was introduced. Pets felt more at ease with the treatment and spend less time travelling to an in-person office visit due to PepiPets Inc.'s at-home testing service.

Key Players Landscape and Outlook

Several companies such as Thermo Fisher Scientific, Inc., Zoetis Services LLC, IDEXX Laboratories, Inc., Heska Corporation, bioMerieux SA, FUJIFILM Holdings America Corporation, Ring Biotechnology Co Ltd., PepiPets, Inc., Bio-Rad Laboratories, Inc., Neogen Corporation, etc. are expanding business by planning and adopting new strategies. They are complying with new strategic initiatives regarding the launches of newly developed veterinary diagnostics to help researchers and strengthen their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments, and partnerships are a few ways through which they are trying to achieve the same.

For instance, in June 2023, IDEXX Laboratories, Inc. announced the launch of the first veterinary diagnostic test available for identifying kidney damage in dogs and cats.

Similarly, in April 2023, Mars, Incorporated and Heska Corporation announced that they had signed a deal whereby Mars would buy Heska for USD 120.00 per share. This would allow Mars Petcare greater coverage in the areas of technology and diagnostics, as well as faster research and development and greater access to pet healthcare solutions on a global scale.

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Veterinary Diagnostics Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. By Product
    • 4.2.1. Instruments
    • 4.2.2. Consumables
  • 4.3. By Technology
    • 4.3.1. Molecular Diagnostics
      • 4.3.1.1. PCR Tests
      • 4.3.1.2. Microarrays
      • 4.3.1.3. Nucleic Acid Sequencing
    • 4.3.2. Immunodiagnostics
      • 4.3.2.1. Lateral Flow Assays
      • 4.3.2.2. ELISA
      • 4.3.2.3. Radioimmunoassays
      • 4.3.2.4. Others
    • 4.3.3. Clinical Biochemistry
      • 4.3.3.1. Clinical Chemistry Analysis
      • 4.3.3.2. Glucose Monitoring
      • 4.3.3.3. Blood Gas and Electrolyte Analysis
    • 4.3.4. Haematology
    • 4.3.5. Others
  • 4.4. By Animal Type
    • 4.4.1. Companion Animals
      • 4.4.1.1. Dogs
      • 4.4.1.2. Cats
      • 4.4.1.3. Horses
      • 4.4.1.4. Others
    • 4.4.2. Livestock
      • 4.4.2.1. Cattle
      • 4.4.2.2. Pigs
      • 4.4.2.3. Poultry
      • 4.4.2.4. Others
  • 4.5. By Application
    • 4.5.1. Infectious Diseases
      • 4.5.1.1. Bacterial Infections
      • 4.5.1.2. Viral Infections
      • 4.5.1.3. Parasitic Infections
      • 4.5.1.4. Others
    • 4.5.2. Endocrinology
    • 4.5.3. Oncology
    • 4.5.4. Cardiology
    • 4.5.5. Others
  • 4.6. By End-user
    • 4.6.1. Veterinary Hospitals and Clinics
    • 4.6.2. Veterinary Reference Laboratories
    • 4.6.3. Others
  • 4.7. By Region
    • 4.7.1. North America
    • 4.7.2. Europe
    • 4.7.3. Asia-Pacific
    • 4.7.4. South America
    • 4.7.5. Middle East and Africa
  • 4.8. By Company Market Share (%), 2023

5. Global Veterinary Diagnostics Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
    • 5.1.2. By Product
      • 5.1.2.1. Consumables
      • 5.1.2.2. Instruments
    • 5.1.3. By Technology
      • 5.1.3.1. Molecular Diagnostics
        • 5.1.3.1.1. PCR Tests
        • 5.1.3.1.2. Microarrays
        • 5.1.3.1.3. Nucleic Acid Sequencing
      • 5.1.3.2. Immunodiagnostics
        • 5.1.3.2.1. Lateral Flow Assays
        • 5.1.3.2.2. ELISA
        • 5.1.3.2.3. Radioimmunoassays
        • 5.1.3.2.4. Others
      • 5.1.3.3. Clinical Biochemistry
        • 5.1.3.3.1. Clinical Chemistry Analysis
        • 5.1.3.3.2. Glucose Monitoring
        • 5.1.3.3.3. Blood Gas and Electrolyte Analysis
      • 5.1.3.4. Haematology
      • 5.1.3.5. Others
    • 5.1.4. By Animal Type
      • 5.1.4.1. Companion Animals
        • 5.1.4.1.1. Dogs
        • 5.1.4.1.2. Cats
        • 5.1.4.1.3. Horses
        • 5.1.4.1.4. Others
      • 5.1.4.2. Livestock
        • 5.1.4.2.1. Cattle
        • 5.1.4.2.2. Pigs
        • 5.1.4.2.3. Poultry
        • 5.1.4.2.4. Others
    • 5.1.5. By Application
      • 5.1.5.1. Infectious Diseases
        • 5.1.5.1.1. Bacterial Infections
        • 5.1.5.1.2. Viral Infections
        • 5.1.5.1.3. Parasitic Infections
        • 5.1.5.1.4. Others
      • 5.1.5.2. Endocrinology
      • 5.1.5.3. Oncology
      • 5.1.5.4. Cardiology
      • 5.1.5.5. Others
    • 5.1.6. By End-user
      • 5.1.6.1. Veterinary Hospitals and Clinics
      • 5.1.6.2. Veterinary Reference Laboratories
      • 5.1.6.3. Others
    • 5.1.7. United States*
      • 5.1.7.1. Market Size & Forecast
        • 5.1.7.1.1. By Value
      • 5.1.7.2. By Product
        • 5.1.7.2.1. Instruments
        • 5.1.7.2.2. Consumables
      • 5.1.7.3. By Technology
        • 5.1.7.3.1. Molecular Diagnostics
          • 5.1.7.3.1.1. PCR Tests
          • 5.1.7.3.1.2. Microarrays
          • 5.1.7.3.1.3. Nucleic Acid Sequencing
        • 5.1.7.3.2. Immunodiagnostics
          • 5.1.7.3.2.1. Lateral Flow Assays
          • 5.1.7.3.2.2. ELISA
          • 5.1.7.3.2.3. Radioimmunoassays
          • 5.1.7.3.2.4. Others
        • 5.1.7.3.3. Clinical Biochemistry
          • 5.1.7.3.3.1. Clinical Chemistry Analysis
          • 5.1.7.3.3.2. Glucose Monitoring
          • 5.1.7.3.3.3. Blood Gas and Electrolyte Analysis
        • 5.1.7.3.4. Haematology
        • 5.1.7.3.5. Others
      • 5.1.7.4. By Animal Type
        • 5.1.7.4.1. Companion Animals
          • 5.1.7.4.1.1. Dogs
          • 5.1.7.4.1.2. Cats
          • 5.1.7.4.1.3. Horses
          • 5.1.7.4.1.4. Others
        • 5.1.7.4.2. Livestock
          • 5.1.7.4.2.1. Cattle
          • 5.1.7.4.2.2. Pigs
          • 5.1.7.4.2.3. Poultry
          • 5.1.7.4.2.4. Others
      • 5.1.7.5. By Application
        • 5.1.7.5.1. Infectious Diseases
          • 5.1.7.5.1.1. Bacterial Infections
          • 5.1.7.5.1.2. Viral Infections
          • 5.1.7.5.1.3. Parasitic Infections
          • 5.1.7.5.1.4. Others
        • 5.1.7.5.2. Endocrinology
        • 5.1.7.5.3. Oncology
        • 5.1.7.5.4. Cardiology
        • 5.1.7.5.5. Others
      • 5.1.7.6. By End-user
        • 5.1.7.6.1. Veterinary Hospitals and Clinics
        • 5.1.7.6.2. Veterinary Reference Laboratories
        • 5.1.7.6.3. Others
    • 5.1.8. Canada
    • 5.1.9. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East and Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Product
  • 6.2. By Technology
  • 6.3. By Animal Type
  • 6.4. By Application
  • 6.5. By End-user
  • 6.6. By Region

7. Macro Environment and Industry Structure

  • 7.1. Demand Supply Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat From New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Patent Landscape
  • 9.2. Regulatory Approvals
  • 9.3. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Thermo Fisher Scientific, Inc.
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products and Services
    • 13.1.4. Financials (As Reported)
    • 13.1.5. Key Market Focus and Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Zoetis Services LLC
  • 13.3. IDEXX Laboratories, Inc.
  • 13.4. Heska Corporation
  • 13.5. bioMerieux SA
  • 13.6. FUJIFILM Holdings America Corporation
  • 13.7. Ring Biotechnology Co Ltd.
  • 13.8. PepiPets, Inc.
  • 13.9. Bio-Rad Laboratories, Inc.
  • 13.10. Neogen Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 3. Global Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 4. Global Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 5. Global Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 6. Global Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global Veterinary Diagnostics Market Share (%), By Region, 2017-2031F
  • Figure 8. North America Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 9. North America Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 10. North America Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 11. North America Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 12. North America Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 13. North America Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America Veterinary Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 15. United States Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. United States Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 17. United States Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 18. United States Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 19. United States Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 20. United States Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 22. Canada Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 23. Canada Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 24. Canada Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 25. Canada Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 26. Canada Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 28. Mexico Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 29. Mexico Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 30. Mexico Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 31. Mexico Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 32. Mexico Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 34. Europe Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 35. Europe Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 36. Europe Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 37. Europe Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 38. Europe Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe Veterinary Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. Germany Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 42. Germany Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 43. Germany Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 44. Germany Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 45. Germany Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 46. France Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. France Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 48. France Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 49. France Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 50. France Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 51. France Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Italy Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 54. Italy Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 55. Italy Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 56. Italy Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 57. Italy Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 59. United Kingdom Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 60. United Kingdom Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 61. United Kingdom Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 62. United Kingdom Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 63. United Kingdom Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Russia Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 66. Russia Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 67. Russia Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 68. Russia Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 69. Russia Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 71. Netherlands Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 72. Netherlands Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 73. Netherlands Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 74. Netherlands Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 75. Netherlands Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. Spain Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 78. Spain Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 79. Spain Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 80. Spain Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 81. Spain Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. Turkey Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 84. Turkey Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 85. Turkey Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 86. Turkey Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 87. Turkey Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Poland Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 90. Poland Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 91. Poland Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 92. Poland Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 93. Poland Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. South America Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 96. South America Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 97. South America Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 98. South America Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 99. South America Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America Veterinary Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. Brazil Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 103. Brazil Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 104. Brazil Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 105. Brazil Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 106. Brazil Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 108. Argentina Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 109. Argentina Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 110. Argentina Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 111. Argentina Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 112. Argentina Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 114. Asia-Pacific Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 115. Asia-Pacific Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 116. Asia-Pacific Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 117. Asia-Pacific Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 118. Asia-Pacific Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific Veterinary Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 120. India Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 121. India Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 122. India Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 123. India Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 124. India Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 125. India Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 126. China Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. China Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 128. China Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 129. China Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 130. China Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 131. China Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 133. Japan Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 134. Japan Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 135. Japan Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 136. Japan Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 137. Japan Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 139. Australia Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 140. Australia Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 141. Australia Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 142. Australia Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 143. Australia Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 145. Vietnam Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 146. Vietnam Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 147. Vietnam Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 148. Vietnam Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 149. Vietnam Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 151. South Korea Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 152. South Korea Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 153. South Korea Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 154. South Korea Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 155. South Korea Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 157. Indonesia Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 158. Indonesia Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 159. Indonesia Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 160. Indonesia Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 161. Indonesia Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 163. Philippines Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 164. Philippines Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 165. Philippines Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 166. Philippines Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 167. Philippines Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 169. Middle East & Africa Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 170. Middle East & Africa Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 171. Middle East & Africa Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 172. Middle East & Africa Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 173. Middle East & Africa Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa Veterinary Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Saudi Arabia Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 177. Saudi Arabia Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 178. Saudi Arabia Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 179. Saudi Arabia Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 180. Saudi Arabia Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. UAE Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 183. UAE Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 184. UAE Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 185. UAE Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 186. UAE Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa Veterinary Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 188. South Africa Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 189. South Africa Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 190. South Africa Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 191. South Africa Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 192. South Africa Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195. By Animal Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 198. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023